Microarray analysis of peripheral blood lymphocytes from ALS patients and the SAFE detection of the KEGG ALS pathway

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Mougeot, Jean Luc C ^a,b   Li, Zhen ^c   Price, Andrea E ^a,b   Wright, Fred A ^c   Brooks, Benjamin R ^a,b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3 ALPHA 2; UBIQUITINATED PROTEIN; UNCLASSIFIED DRUG; MESSENGER RNA; PROTEASOME; PROTEINASE INHIBITOR; UBIQUITIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANALYTIC METHOD; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; HUMAN CELL; KYOTO ENCYCLOPEDIA OF GENES AND GENOMES; LINEAR MODELS FOR MICROARRAY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOTONEURON; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SIGNIFICANCE ANALYSIS OF FUNCTION AND EXPRESSION; SIGNIFICANCE ANALYSIS OF MICROARRAYS; SOD1 GENE; UBR2 GENE; AGED; BLOOD; CASE CONTROL STUDY; CELL SEPARATION; DNA MICROARRAY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MIDDLE AGED; MONONUCLEAR CELL; NUCLEIC ACID AMPLIFICATION;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; CELL SEPARATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; UBIQUITIN;

EID: 80054862015     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-74     Document Type: Article

References (54)

1. TDP-43 and ubiquitinated cytoplasmic aggregates in sporadic ALS are low frequency and widely distributed in the lower motor neuron columns independent of disease spread. Bodansky A, Kim JM, Tempest L, Velagapudi A, Libby R, Ravits J, Amyotroph Lateral Scler 2010 11 3 321 327 10.3109/17482961003602363 20225928
2. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, Lemmens R, Schelhaas HJ, Groen EJ, Huisman MH, van der Kooi AJ, de Visser M, Dahlberg C, Estrada K, Rivadeneira F, Hofman A, Zwarts MJ, van Doormaal PT, Rujescu D, Strengman E, Giegling I, Muglia P, Tomik B, Slowik A, Uitterlinden AG, Hendrich C, Waibel S, Meyer T, Ludolph AC, Glass JD, et al. Nat Genet 2009 41 10 1083 1087 10.1038/ng.442 19734901
3. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. van Es MA, van Vught PW, Blauw HM, Franke L, Saris CG, Andersen PM, van den Bosch L, de Jong SW, van't Slot R, Birve A, Lemmens R, de Jong V, Baas F, Schelhaas HJ, Sleegers K, van Broeckhoven C, Wokke JH, Wijmenga C, Robberecht W, Veldink JH, Ophoff RA, van den Berg LH, Lancet Neurol 2007 6 10 869 77 10.1016/S1474-4422(07)70222-3 17827064 (Pubitemid 47407791)
4. Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis. van Es MA, van Vught PW, Veldink JH, Andersen PM, Birve A, Lemmens R, Cronin S, van der Kooi AJ, de Visser M, Schelhaas HJ, Hardiman O, Ragoussis I, Lambrechts D, Robberecht W, Wokke JH, Ophoff RA, van den Berg LH, Amyotroph Lateral Scler 2009 10 5-6 441 7 10.3109/17482960802673042 19922138
5. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. van Es MA, van Vught PW, Blauw HM, Franke L, Saris CG, van den Bosch L, de Jong SW, de Jong V, Baas F, van't Slot R, Lemmens R, Schelhaas HJ, Birve A, Sleegers K, van Broeckhoven C, Schymick JC, Traynor BJ, Wokke JH, Wijmenga C, Robberecht W, Andersen PM, Veldink JH, Ophoff RA, van den Berg LH, Nat Genet 2008 40 1 29 31 10.1038/ng.2007.52 18084291
6. Analysis of the UNC13A gene as a risk factor for sporadic amyotrophic lateral sclerosis. Daoud H, Belzil V, Desjarlais A, Camu W, Dion PA, Rouleau GA, Arch Neurol 2010 67 4 516 7 20385924
7. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, Vance C, Johnson L, Veldink JH, van Es MA, van den Berg LH, Robberecht W, van Damme P, Hardiman O, Farmer AE, Lewis CM, Butler AW, Abel O, Andersen PM, Fogh I, Silani V, Chi A, Traynor BJ, Melki J, Meininger V, Landers JE, McGuffin P, Glass JD, Pall H, Leigh PN, Hardy J, et al. Lancet Neurol 2010 9 10 986 94 10.1016/S1474-4422(10)70197-6 20801717
8. The Euro-MOTOR project. http://www.euromotorproject.eu
9. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Kudo LC, Parfenova L, Vi N, Lau K, Pomakian J, Valdmanis P, Rouleau GA, Vinters HV, Wiedau-Pazos M, Karsten SL, Hum Mol Genet 2010 19 16 3233 3253 10.1093/hmg/ddq232 20530642
10. Specific electron transport chain abnormalities in amyotrophic lateral sclerosis. Lin J, Diamanduros A, Chowdhury SA, Scelsa S, Latov N, Sadiq SA, J Neurol 2009 256 5 774 782 10.1007/s00415-009-5015-8 19240958
11. Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients. Saris CG, Horvath S, van Vught PW, van Es MA, Blauw HM, Fuller TF, Langfelder P, DeYoung J, Wokke JH, Veldink JH, van den Berg LH, Ophoff RA, BMC Genomics 2009 10 405 10.1186/1471-2164-10-405 19712483
12. SOD1 mRNA expression in sporadic amyotrophic lateral sclerosis. Gagliardi S, Cova E, Davin A, Guareschi S, Abel K, Alvisi E, Laforenza U, Ghidoni R, Cashman JR, Ceroni M, Cereda C, Neurobiol Dis 2010 39 2 198 203 10.1016/j.nbd.2010.04.008 20399857
13. Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS). Zhang R, Hadlock KG, Do H, Yu S, Honrada R, Champion S, Forshew D, Madison C, Katz J, Miller RG, McGrath MS, J Neuroimmunol 2010 230 1-2 114 123 20884065
14. From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Lincecum JM, Vieira FG, Wang MZ, Thompson K, De Zutter GS, Kidd J, Moreno A, Sanchez R, Carrion IJ, Levine BA, Al-Nakhala BM, Sullivan SM, Gill A, Perrin S, Nat Genet 2010 42 5 392 9 10.1038/ng.557 20348957
15. Implications of blood-brain barrier disruption in ALS. Garbuzova-Davis S, Saporta S, Sanberg PR, Amyotroph Lateral Scler 2008 9 6 375 376 10.1080/17482960802160990 18608097
16. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. Palmer C, Diehn M, Alizadeh AA, Brown PO, BMC Genomics 2006 7 115 10.1186/1471-2164-7-115 16704732
17. Variability of gene expression profiles in human blood and lymphoblastoid cell lines. Min JL, Barrett A, Watts T, Pettersson FH, Lockstone HE, Lindgren CM, Taylor JM, Allen M, Zondervan KT, McCarthy MI, BMC Genomics 2010 11 96 10.1186/1471-2164-11-96 20141636
18. Linear models for microarray data analysis: hidden similarities and differences. Kerr MK, J Comput Biol 2003 10 6 891 901 10.1089/106652703322756131 14980016 (Pubitemid 38156404)
19. Significance analysis of microarrays applied to the ionizing radiation response. Tusher VG, Tibshirani R, Chu G, Proc Natl Acad Sci USA 2001 98 9 5116 5121 10.1073/pnas.091062498 11309499 (Pubitemid 32397092)
20. Significance analysis of functional categories in gene expression studies: a structured permutation approach. Barry WT, Nobel AB, Wright FA, Bioinformatics 2005 21 9 1943 1949 10.1093/bioinformatics/bti260 15647293 (Pubitemid 40668030)
21. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Brooks BR, Miller RG, Swash M, Munsat TL, Amyotroph Lateral Scler Other Motor Neuron Disord 2000 1 5 293 299 10.1080/146608200300079536 11464847
22. Simple and cost-effective isolation of monocytes from buffy coats. Repnik U, Knezevic M, Jeras M, J Immunol Methods 2003 278 1-2 283 292 10.1016/S0022-1759(03)00231-X 12957415 (Pubitemid 37281210)
23. Reassessing design and analysis of two-colour microarray experiments using mixed effects models. Rosa GJ, Steibel JP, Tempelman RJ, Comp Funct Genomics 2005 6 3 123 131 10.1002/cfg.464 18629220 (Pubitemid 40691801)
24. The NCBI Gene Expression Omnibus database. http://www.ncbi.nlm.nih.gov/ geo
25. The statistics of identifying differentially expressed genes in Expresso and TM4: a comparison. Sioson AA, Mane SP, Li P, Sha W, Heath LS, Bohnert HJ, Grene R, BMC Bioinformatics 2006 7 215 10.1186/1471-2105-7-215 16626497 (Pubitemid 44110276)
26. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Münch C, Rosenbohm A, Sperfeld AD, Uttner I, Reske S, Krause BJ, Sedlmeier R, Meyer T, Hanemann CO, Stumm G, Ludolph AC, Ann Neurol 2005 58 5 777 80 10.1002/ana.20631 16240349 (Pubitemid 41552554)
27. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F, Pradat PF, Camu W, Meininger V, Dupre N, Rouleau GA, Nat Genet 2008 40 5 572 4 10.1038/ng.132 18372902 (Pubitemid 351601218)
28. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. Liu-Yesucevitz L, Bilgutay A, Zhang YJ, Vanderwyde T, Citro A, Mehta T, Zaarur N, McKee A, Bowser R, Sherman M, Petrucelli L, Wolozin B, PLoS One 2010 5 10 13250 10.1371/journal.pone.0013250 20948999
29. C1D and hMtr4p associate with the human exosome subunit PM/Scl-100 and are involved in pre-rRNA processing. Schilders G, van Dijk E, Pruijn GJ, Nucleic Acids Res 2007 35 8 2564 2572 10.1093/nar/gkm082 17412707 (Pubitemid 47073670)
30. Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. Jurica MS, Licklider LJ, Gygi SR, Grigorieff N, Moore MJ, RNA 2002 8 4 426 439 10.1017/S1355838202021088 11991638 (Pubitemid 34437714)
31. Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family. Kovar H, Sarcoma 2011 2011 837474 21197473
32. RNA processing defects associated with diseases of the motor neuron. Kolb SJ, Sutton S, Schoenberg DR, Muscle Nerve 2010 41 1 5 17 10.1002/mus.21428 19697368
33. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A, Caillier SJ, Ban M, Goris A, Barcellos LF, Lincoln R, McCauley JL, Sawcer SJ, Compston DA, Dubois B, Hauser SL, Garcia-Blanco MA, Pericak-Vance MA, Haines JL, Multiple Sclerosis Genetics Group, Nat Genet 2007 39 9 1083 1091 10.1038/ng2103 17660817 (Pubitemid 47340652)
34. Identification and characterization of a novel Nogo-interacting mitochondrial protein (NIMP). Hu WH, Hausmann ON, Yan MS, Walters WM, Wong PK, Bethea JR, J Neurochem 2002 81 1 36 45 10.1046/j.1471-4159.2002.00788.x 12067236 (Pubitemid 34808852)
35. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP, Proc Natl Acad Sci USA 2005 102 43 15545 15550 10.1073/pnas.0506580102 16199517 (Pubitemid 41528093)
36. Heading down the wrong pathway: on the influence of correlation within gene sets. Gatti DM, Barry WT, Nobel AB, Rusyn I, Wright FA, BMC Genomics 2010 11 574 10.1186/1471-2164-11-574 20955544
37. The KEGG ALS Pathway. http://www.genome.jp/kegg/pathway/hsa/hsa05014.html
38. The AmiGO gene ontology database. http://amigo.geneontology.org
39. Ubr1 and Ubr2 function in a quality control pathway for degradation of unfolded cytosolic proteins. Nillegoda NB, Theodoraki MA, Mandal AK, Mayo KJ, Ren HY, Sultana R, Wu K, Johnson J, Cyr DM, Caplan AJ, Mol Biol Cell 2010 21 13 2102 2116 10.1091/mbc.E10-02-0098 20462952
40. Prevention of muscle disuse atrophy by MG132 proteasome inhibitor. Jamart C, Raymackers JM, Li An G, Deldicque L, Francaux M, Muscle Nerve 2010 43 5 708 715
41. Increased caspase activation and decreased TDP-43 solubility in progranulin knockout cortical cultures. Kleinberger G, Wils H, Ponsaerts P, Joris G, Timmermans JP, Van Broeckhoven C, Kumar-Singh S, J Neurochem 2010 115 3 735 747 10.1111/j.1471-4159.2010.06961.x 20731760
42. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. Jury EC, Kabouridis PS, Abba A, Mageed RA, Isenberg DA, Arthritis Rheum 2003 48 5 1343 1354 10.1002/art.10978 12746907 (Pubitemid 36554533)
43. Use of normalization methods for analysis of microarrays containing a high degree of gene effects. Ni TT, Lemon WJ, Shyr Y, Zhong TP, BMC Bioinformatics 2008 9 505 10.1186/1471-2105-9-505 19040742
44. Evaluating different methods of microarray data normalization. Fujita A, Sato JR, Rodrigues Lde O, Ferreira CE, Sogayar MC, BMC Bioinformatics 2006 7 469 10.1186/1471-2105-7-469 17059609 (Pubitemid 44773838)
45. Exome sequencing reveals VCP mutations as a cause of familial ALS. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, van Deerlin VM, Trojanowski JQ, Gibbs JR, Brunetti M, Gronka S, Wuu J, Ding J, McCluskey L, Martinez-Lage M, Falcone D, Hernandez DG, Arepalli S, Chong S, Schymick JC, Rothstein J, Landi F, Wang YD, Calvo A, Mora G, Sabatelli M, Monsurr MR, Battistini S, Salvi F, Spataro R, Sola P, Borghero G, et al. Neuron 2010 68 5 857 64 10.1016/j.neuron.2010.11.036 21145000
46. Role of N-end rule ubiquitin ligases UBR1 and UBR2 in regulating the leucine-mTOR signaling pathway. Kume K, Iizumi Y, Shimada M, Ito Y, Kishi T, Yamaguchi Y, Handa H, Genes Cells 2010 15 4 339 49 10.1111/j.1365-2443.2010. 01385.x 20298436
47. Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity. Niwa J, Ishigaki S, Hishikawa N, Yamamoto M, Doyu M, Murata S, Tanaka K, Taniguchi N, Sobue G, J Biol Chem 2002 277 39 36793 36798 10.1074/jbc.M206559200 12145308
48. Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis. Sone J, Niwa J, Kawai K, Ishigaki S, Yamada S, Adachi H, Katsuno M, Tanaka F, Doyu M, Sobue G, J Neurosci Res 2010 88 1 123 135 10.1002/jnr.22175 19610091
49. Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations. De Marco G, Lupino E, Calvo A, Moglia C, Buccinn B, Grifoni S, Ramondetti C, Lomartire A, Rinaudo MT, Piccinini M, Giordana MT, Chi A, Acta Neuropathol 2011 121 5 611 22 10.1007/s00401-010- 0786-7 21120508
50. Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS). Hanson KA, Kim SH, Wassarman DA, Tibbetts RS, J Biol Chem 285 15 11068 11072
51. Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1. Kim SH, Shi Y, Hanson KA, Williams LM, Sakasai R, Bowler MJ, Tibbetts RS, J Biol Chem 2009 284 12 8083 8092 10.1074/jbc.M808064200 19112176
52. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, Yang Y, Fecto F, Shi Y, Zhai H, Jiang H, Hirano M, Rampersaud E, Jansen GH, Donkervoort S, Bigio EH, Brooks BR, Ajroud K, Sufit RL, Haines JL, Mugnaini E, Pericak-Vance MA, Siddique T, Nature 2011 477 7363 211 5 10.1038/nature10353 21857683
53. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Kleijnen MF, Shih AH, Zhou P, Kumar S, Soccio RE, Kedersha NL, Gill G, Howley PM, Mol Cell 6 2 409 19
54. An immunohistochemical study of ubiquitin in the skin of sporadic amyotrophic lateral sclerosis. Watanabe T, Okeda Y, Yamano T, Ono S, J Neurol Sci 2010 298 1-2 52 56 10.1016/j.jns.2010.08.026 20850799